Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Decreased cervical epithelial sensitivity to nonoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safety.

Lozenski K, Ownbey R, Wigdahl B, Kish-Catalone T, Krebs FC.

BMC Pharmacol Toxicol. 2012 Oct 1;13:9. doi: 10.1186/2050-6511-13-9.

2.

Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides.

Catalone BJ, Kish-Catalone TM, Budgeon LR, Neely EB, Ferguson M, Krebs FC, Howett MK, Labib M, Rando R, Wigdahl B.

Antimicrob Agents Chemother. 2004 May;48(5):1837-47.

3.

Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives.

Fichorova RN, Bajpai M, Chandra N, Hsiu JG, Spangler M, Ratnam V, Doncel GF.

Biol Reprod. 2004 Sep;71(3):761-9. Epub 2004 May 5.

PMID:
15128598
4.

Comparative safety evaluation of the candidate vaginal microbicide C31G.

Catalone BJ, Kish-Catalone TM, Neely EB, Budgeon LR, Ferguson ML, Stiller C, Miller SR, Malamud D, Krebs FC, Howett MK, Wigdahl B.

Antimicrob Agents Chemother. 2005 Apr;49(4):1509-20.

5.

Establishing a Th17 based mouse model for preclinical assessment of the toxicity of candidate microbicides.

Li LZ, Yang Y, Yuan SH, Wan YM, Qiu C, Feng YL, Xu JQ, Zhang XY.

Chin Med J (Engl). 2010 Dec;123(23):3381-8.

PMID:
22166518
6.

Preclinical assessment of the proinflammatory potential of microbicide candidates.

Doncel GF, Chandra N, Fichorova RN.

J Acquir Immune Defic Syndr. 2004 Oct;37 Suppl 3:S174-80.

PMID:
16419269
7.

Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina).

Patton DL, Kidder GG, Sweeney YC, Rabe LK, Hillier SL.

Am J Obstet Gynecol. 1999 May;180(5):1080-7.

PMID:
10329859
8.

Mucosal integrity and inflammatory markers in the female lower genital tract as potential screening tools for vaginal microbicides.

Su HI, Schreiber CA, Fay C, Parry S, Elovitz MA, Zhang J, Shaunik A, Barnhart K.

Contraception. 2011 Nov;84(5):525-32. doi: 10.1016/j.contraception.2011.02.010. Epub 2011 Mar 29.

9.

Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation.

Fichorova RN, Zhou F, Ratnam V, Atanassova V, Jiang S, Strick N, Neurath AR.

Antimicrob Agents Chemother. 2005 Jan;49(1):323-35.

10.

Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.

Trifonova RT, Pasicznyk JM, Fichorova RN.

Antimicrob Agents Chemother. 2006 Dec;50(12):4005-10. Epub 2006 Oct 9.

11.

Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes. A randomized clinical trial.

Martin HL Jr, Stevens CE, Richardson BA, Rugamba D, Nyange PM, Mandaliya K, Ndinya-Achola J, Kreiss JK.

Sex Transm Dis. 1997 May;24(5):279-83.

PMID:
9153737
12.

Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.

Stafford MK, Ward H, Flanagan A, Rosenstein IJ, Taylor-Robinson D, Smith JR, Weber J, Kitchen VS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):327-31.

PMID:
9525433
13.

Biomarkers of leukocyte traffic and activation in the vaginal mucosa.

Trifonova RT, Bajpai M, Pasicznyk JM, Chandra N, Doncel GF, Fichorova RN.

Biomarkers. 2007 Nov-Dec;12(6):608-22.

PMID:
17852080
14.
15.

Application of optical coherence tomography for monitoring changes in cervicovaginal epithelial morphology in macaques: potential for assessment of microbicide safety.

Vincent KL, Bell BA, Rosenthal SL, Stanberry LR, Bourne N, Sweeney YT, Patton DL, Motamedi M.

Sex Transm Dis. 2008 Mar;35(3):269-75.

PMID:
18091028
16.

Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission.

Yang J, Li L, Jin H, Tan S, Qiu J, Yang L, Ding Y, Jiang ZH, Jiang S, Liu S.

AIDS Res Hum Retroviruses. 2012 Nov;28(11):1498-508. doi: 10.1089/AID.2012.0084. Epub 2012 Sep 11.

PMID:
22867271
17.

Assessment of cervicovaginal cytokine levels following exposure to microbicide Nisin gel in rabbits.

Aranha CC, Gupta SM, Reddy KV.

Cytokine. 2008 Jul;43(1):63-70. doi: 10.1016/j.cyto.2008.04.005. Epub 2008 May 29.

PMID:
18513989
19.

The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission.

Fichorova RN, Tucker LD, Anderson DJ.

J Infect Dis. 2001 Aug 15;184(4):418-28. Epub 2001 Jul 16.

PMID:
11471099
20.

Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations.

Harwood B, Meyn LA, Ballagh SA, Raymond EG, Archer DF, Creinin MD.

Am J Obstet Gynecol. 2008 Jan;198(1):32.e1-7. doi: 10.1016/j.ajog.2007.05.020.

Supplemental Content

Support Center